Healthcare provider profile · identity verified

Roberto Larios, M.D.

Emergency Medicine · LEOMINSTER, MA · NPI 1679771588

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	703	25
Divalproex Sodium	Divalproex Sodium	649	11
Quetiapine Fumarate	Quetiapine Fumarate	624	13
Gabapentin	Gabapentin	431	17
Tamsulosin Hcl	Tamsulosin Hcl	421	13
Risperidone	Risperidone	417	suppressed
Trazodone Hcl	Trazodone Hcl	374	16
Amlodipine Besylate	Amlodipine Besylate	368	15
Furosemide	Furosemide	298	18
Metoprolol Tartrate	Metoprolol Tartrate	293	15
Mirtazapine	Mirtazapine	292	13
Levetiracetam	Levetiracetam	289	18
Metformin Hcl	Metformin Hcl	284	11
Duloxetine Hcl	Duloxetine Hcl	263	suppressed
Lisinopril	Lisinopril	254	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	230	suppressed
Simvastatin	Simvastatin	214	suppressed
Baclofen	Baclofen	210	suppressed
Famotidine	Famotidine	201	suppressed
Divalproex Sodium Er	Divalproex Sodium	191	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	190	11
Sertraline Hcl	Sertraline Hcl	178	suppressed
Lamotrigine	Lamotrigine	175	suppressed
Eliquis	Apixaban	168	11
Benztropine Mesylate	Benztropine Mesylate	166	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	164	suppressed
Buspirone Hcl	Buspirone Hcl	146	suppressed
Olanzapine	Olanzapine	136	suppressed
Aripiprazole	Aripiprazole	122	suppressed
Haloperidol	Haloperidol	121	suppressed
Finasteride	Finasteride	116	suppressed
Propranolol Hcl	Propranolol Hcl	115	suppressed
Metoprolol Succinate	Metoprolol Succinate	110	suppressed
Carvedilol	Carvedilol	109	suppressed
Potassium Chloride	Potassium Chloride	94	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	81	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	79	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	76	suppressed
Xarelto	Rivaroxaban	75	suppressed
Glipizide	Glipizide	66	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	60	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	59	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	59	suppressed
Glipizide Er	Glipizide	58	suppressed
Citalopram Hbr	Citalopram Hydrobromide	56	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	55	suppressed
Atenolol	Atenolol	54	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	54	suppressed
Clonidine Hcl	Clonidine Hcl	53	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	53	suppressed
Perphenazine	Perphenazine	53	suppressed
Mesalamine Er	Mesalamine	52	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	52	suppressed
Roflumilast	Roflumilast	52	suppressed
Lactulose	Lactulose	51	13
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	49	suppressed
Midodrine Hcl	Midodrine Hcl	49	suppressed
Oxcarbazepine	Oxcarbazepine	47	suppressed
Donepezil Hcl	Donepezil Hcl	45	suppressed
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	45	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	44	suppressed
Paliperidone Er	Paliperidone	42	suppressed
Warfarin Sodium	Warfarin Sodium	42	suppressed
Ezetimibe	Ezetimibe	41	suppressed
Glycopyrrolate	Glycopyrrolate	41	suppressed
Tizanidine Hcl	Tizanidine Hcl	40	suppressed
Prezcobix	Darunavir/Cobicistat	36	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Hydrocortisone	Hydrocortisone	34	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	34	suppressed
Topiramate	Topiramate	33	suppressed
Captopril	Captopril	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Valsartan	Valsartan	29	suppressed
Torsemide	Torsemide	28	suppressed
Losartan Potassium	Losartan Potassium	27	suppressed
Ketoconazole	Ketoconazole	26	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Scopolamine	Scopolamine	26	suppressed
Xifaxan	Rifaximin	26	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	25	suppressed
Jardiance	Empagliflozin	23	suppressed
Methotrexate	Methotrexate Sodium	23	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Ursodiol	Ursodiol	20	suppressed
Heparin Sodium	Heparin Sodium,porcine	19	suppressed
Levemir	Insulin Detemir	19	suppressed
Prednisone	Prednisone	19	11
Ziprasidone Hcl	Ziprasidone Hcl	18	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	15	suppressed
Clozapine	Clozapine	15	suppressed
Konvomep	Omeprazole/Sodium Bicarbonate	15	suppressed
Sodium Chloride	0.9 % Sodium Chloride	15	suppressed
Lidocaine Hcl	Lidocaine Hcl	14	suppressed
Methimazole	Methimazole	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	14	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	13	11
Digoxin	Digoxin	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Ingrezza	Valbenazine Tosylate	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Albuterol Sulfate	Albuterol Sulfate	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	11	suppressed
Haloperidol Lactate	Haloperidol Lactate	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Risperidone Er	Risperidone Microspheres	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error